ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0947

Cytokine Competent Gut-joint Migratory T Cells Contribute to Inflammation in the Joint

Adam Lefferts1, David Claypool1, Eric Norman1, Uma Kantheti1 and Kristine Kuhn2, 1University of Colorado, Anschutz Medical Campus, Aurora, CO, 2University of Colorado Anschutz Medical Campus, Aurora, CO

Meeting: ACR Convergence 2021

Keywords: Ankylosing spondylitis (AS), Autoinflammatory diseases, spondyloarthritis, T Cell, Tumor necrosis factor (TNF)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Abstracts: Spondyloarthritis Including PsA – Basic Science (0944–0947)

Session Type: Abstract Session

Session Time: 9:45AM-10:00AM

Background/Purpose: Although studies have identified the presence of gut-associated cells in the enthesis of joints affected by spondyloarthritis, a direct link through cellular transit between the gut and joint has yet to be formally demonstrated. Using the KikGR transgenic mice to label in situ and track cellular trafficking from the distal colon to the joint under inflammatory conditions of both the gut and joint, we aimed to determine the relative roles of gut-trafficked T cells in the joint.

Methods: KikGR x TNFDARE/+ mice, which spontaneously develop Crohn’s like intestinal inflammation and spondyloarthritis-like joint inflammation, and KikGR x TNF+/+ controls underwent colonoscopy-guided photo-labeling of the distal colon epithelium. At 72 hours after photo-labelling, we harvested the popliteal lymph nodes (PLNs) from both KikGR x TNFDARE/+ and KikGR x TNF+/+ mice. Following magnetic sorting of T cells by negative selection, T cells were stimulated with anti-CD3 anti-CD28 for 4 hours in the presence of protein transport blockade. T cells then were evaluated by flow cytometry for activation, cytokine production, and transcription factors. To assess the contribution of gut-derived T cells to disease, we reconstituted Rag1-/- mice with colon epithelium associated T cells from and TNFDARE/+ and TNF+/+ donors harvested by negative selection magnetic sorting. After 8 weeks of homeostatic proliferation, we assessed joint inflammation by histology 5 days following injection of complete Freund’s adjuvant (CFA) into the left hind hock.

Results: 72 hours following photo-labeling, gut-trafficked T cells are observed in the Achilles enthesis in equal proportions (~10% of total T cells) between TNFDARE/+ and TNF+/+ mice. In the PLNs, photo-labeled T cells expressed markers of terminal differentiation, with 51% of labeled cells Foxp3+ and 19% Roryt+, compared to 10% and 1.7% in the unlabeled fraction, respectively (P< 0.01), similar in both TNFDARE/+ and TNF+/+ mice. Ex vivo stimulation of T cells isolated from the PLNs demonstrated significant enrichment of TNF and IL-17A production in the photo-labeled gut-derived T cells compared to unlabeled cells. As expected, gut-derived T cells derived from TNFDARE/+ animals produced higher levels of TNF compared to littermate controls (45% vs 5%, P=0.1); However, while we observed a large and significant enrichment for Il-17A positivity in greater proportion within gut-derived cells in TNF+/+ mice (41% vs 1%, P< 0.0001) this enrichment was smaller and not significant in the TNFDARE/+ (29% vs 5% P =0.2). Transfer of gut-derived T cells into Rag1-/- mice resulted in moderately increased inflammation in recipients of TNF+/+ T cells (P=0.056), and a significant increase in inflammation in recipients of TNFDARE/+ cells (P=0.01), compared to unmanipulated Rag1-/- mice, when challenged with hock injection of CFA.

Conclusion: Our data demonstrate a direct link between the gut and joint through trafficking of gut-derived T cells with the potential to be directly pathogenic through production of pro-inflammatory cytokines like IL-17 and TNF and exacerbation of joint inflammation. Altogether our data suggest a means by which gut-derived T cells may drive joint pathology.


Disclosures: A. Lefferts, None; D. Claypool, None; E. Norman, None; U. Kantheti, None; K. Kuhn, None.

To cite this abstract in AMA style:

Lefferts A, Claypool D, Norman E, Kantheti U, Kuhn K. Cytokine Competent Gut-joint Migratory T Cells Contribute to Inflammation in the Joint [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/cytokine-competent-gut-joint-migratory-t-cells-contribute-to-inflammation-in-the-joint/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cytokine-competent-gut-joint-migratory-t-cells-contribute-to-inflammation-in-the-joint/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology